Johnson & Johnson's $2.2B Settles Huge Healthcare Fraud Case

Johnson & Johnson's $2.2B Settle's Huge Healthcare Fraud CaseJohnson & Johnson has been one the most prominent brand names in the United States for decades, but now it holds the dubious distinction of settling one of the largest healthcare fraud settlements in U.S. history.
Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability stemming from allegations tied to the prescription drugs Risperdal, Invega and Natrecor.
Those allegations include promoting the drugs for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the nation’s largest long-term care pharmacy provider.
The global resolution covers criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion.
“The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust,” said Attorney General Eric Holder.  “This multibillion-dollar resolution demonstrates the Justice Department’s firm commitment to preventing and combating all forms of health care fraud.  And it proves our determination to hold accountable any corporation that breaks the law and enriches its bottom line at the expense of the American people.”
The deal settles criminal fines and forfeiture for violations of the law and civil settlements based on the False Claims Act.
“When companies put profit over patients’ health and misuse taxpayer dollars, we demand accountability,” said Associate Attorney General Tony West.  “In addition to significant monetary sanctions, we will ensure that non-monetary measures are in place to facilitate change in corporate behavior and help ensure the playing field is level for all market participants.”
The settlement requires Johnson & Johnson to adhere to stringent rules under a Corporate Integrity Agreement (CIA) with the Department of Health and Human Services Office of Inspector General (HHS-OIG).
This agreement is suppose to increase accountability and transparency and prevent future fraud and abuse.
Here is the link to all documents available in the Johnson & Johnson settlement.

Leave a Reply

Your email address will not be published. Required fields are marked *